Preclinical Pharmacokinetics and Biodistribution of LR004, a Novel Antiepidermal Growth Factor Receptor Monoclonal Antibody
LR004 is a novel chimeric (human/mouse) monoclonal antibody developed for the treatment of advanced colorectal carcinoma with detectable epidermal growth factor receptor (EGFR) expression. We aimed to investigate the preclinical pharmacokinetics (PK) and in vivo biodistribution of LR004. The PK prof...
Main Authors: | Ying Zheng, Guifang Dou, Shuchen Liu, Zhiyun Meng, Eric I. Tsao, Gang Yu, Xiaoxia Zhu, Ruolan Gu, Zhuona Wu, Yunbo Sun, Peng Han, Hui Gan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/29/2/545 |
Similar Items
-
Molecular Imaging and Preclinical Studies of Radiolabeled Long-Term RGD Peptides in U-87 MG Tumor-Bearing Mice
by: Wei-Lin Lo, et al.
Published: (2021-05-01) -
Ocular Biodistribution Studies using Molecular Imaging
by: Ana Castro-Balado, et al.
Published: (2019-05-01) -
Development of novel radiolabeled antibody-conjugated graphene quantum dots for targeted in vivo breast cancer imaging and biodistribution studies
by: Raziyeh Ganji Arjenaki, et al.
Published: (2024-02-01) -
Biodistribution studies for cell therapy products: Current status and issues
by: Yoshiteru Kamiyama, et al.
Published: (2021-12-01) -
Protocols for Dual Tracer PET/SPECT Preclinical Imaging
by: Julia E. Blower, et al.
Published: (2020-05-01)